galactosamine has been researched along with caryophyllene in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, HI; Choi, HS; Choi, JW; Hong, JM; Hwan Kwak, J; Kook Lee, S; Lee, DU; Lee, SM | 1 |
1 other study(ies) available for galactosamine and caryophyllene
Article | Year |
---|---|
β-Caryophyllene alleviates D-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the TLR4 and RAGE signaling pathways.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cytokines; Cytoprotection; Disease Models, Animal; Galactosamine; Inflammation Mediators; Kupffer Cells; Lipopolysaccharides; Liver; Liver Failure; Male; Mice, Inbred ICR; Mitogen-Activated Protein Kinases; Polycyclic Sesquiterpenes; Receptor for Advanced Glycation End Products; Sesquiterpenes; Signal Transduction; Time Factors; Toll-Like Receptor 4 | 2015 |